Insider filing · ORKA
Laura Lee Sandler
Chief Operating Officer
profile →
Oruka Therapeutics, Inc.
ORKA · Healthcare · 27 filings in 24 months
ticker →
Laura Lee Sandler sold $253K of Oruka Therapeutics (ORKA)
Executed May 1, disclosed May 1, the same day.
Value, as filed
$253K
4,000 sh across 2 lots
Executed
May 1
the trade date, as filed
Disclosed
May 1
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LSLaura Lee Sandler (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $424K of ORKA (4,500 sh across 2 lots, as filed), executed Jul 1.
The name
ORKAHealthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Laura Lee Sandler in ORKA
ORKASALE
Oruka Therapeutics, Inc.
$368K4,000 sh × $92.01
Exec Sep 1
Filed Sep 1 · 6:36 PM ET ORKASALE Oruka Therapeutics, Inc. $424K
4,500 sh across 2 lots
Exec Jul 1
Filed Jul 1 · 7:58 PM ET ORKASALE Oruka Therapeutics, Inc. $246K
8,748 sh × $28.17
Exec Jan 2
Filed Jan 2 · 5:30 PM ET